Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 952 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ablynx ALX-0081 proven effective in ACS patients

Ablynx’s anti-vWF Nanobody is a bivalent construct, consisting of two Nanobodies targeting the vWF, which has an increased potency compared with the monovalent format. The open-label multi-national, multi-institutional

FDA approves IntelGenx anti-depressant drug

CPI-300 is a 450 mg single dose, high-strength formulation of Bupropion hydrochloride (HCl), the active ingredient in Wellbutrin XL. IntelGenx president and CEO Horst Zerbe said they believe

DCGI approves Intercell, Biological E JE vaccine

Biological E. and Intercell entered into a contract agreement in 2005 to develop, manufacture, commercialize, and distribute Intercell’s Japanese Encephalitis vaccine in India and the Indian subcontinent. The

BDSI begins buprenorphine, naloxone study

BEMA buprenorphine/naloxone which contains the same drug components as Suboxone is indicated for the treatment of opioid dependence. The study, BNX-102, will select the final doses of BEMA